Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
FY2025 results briefing session script
by JCR Pharmaceuticals
FY2025 results briefing session movie
by JCR Pharmaceuticals
FY2025 results briefing session material
by JCR Pharmaceuticals
Consolidated financial results for the year ended March 31, 2026 (FY2025)
by JCR Pharmaceuticals
Notice concerning partial corrections to the annual securities report
by JCR Pharmaceuticals
Revision of consolidated financial forecasts for fiscal year ended Mar 31, 2026
by JCR Pharmaceuticals
FY2025 third quarter results briefing session script
by JCR Pharmaceuticals
FY2025-Q3 financial report (Oct. 1-Dec. 31, 2025)
by JCR Pharmaceuticals
Revision of consolidated financial forecasts for fiscal year ended March 31, 2026
by JCR Pharmaceuticals
Recognition of subsidy income as extraordinary income
by JCR Pharmaceuticals
1
2
3
4
Privacy Preference Center
Privacy Preferences
